Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nanosphere Health Sciences Inc. C.NSHS

Alternate Symbol(s):  NSHSF

Healthcare Cannabis
NanoSphere Health Sciences Inc. is a nano-biotechnology company. The Company is focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. The Company has created a patented NanoSphere Deliver System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries. Its wholly owned subsidiary is NanoSphere Health Sciences, LLC (NanoSphere LLC). NanoSphere LLC is the Company’s operating division in the United States.


CSE:NSHS - Post by User

Nanosphere Health Sciences Inc. > NanoSphere Developing Production Lab at Delta 9 Cannabis
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Latebloomer1010on Mar 12, 2019 4:13pm
91 Views
Post# 29475329

RE:RE:NanoSphere Developing Production Lab at Delta 9 Cannabis

RE:RE:NanoSphere Developing Production Lab at Delta 9 Cannabis

Retail prices in US dollars:
 

  • Transdermal: $25 - $45

  • Trans-nasal: $24 - $30

  • CBD: $25

  • Oral: $30 - $40 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities